Hemispherx BioPharma (HEB) Stock Price Down 9.4%

Share on StockTwits

Shares of Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) dropped 9.4% on Wednesday . The company traded as low as $0.14 and last traded at $0.14. Approximately 549,894 shares changed hands during mid-day trading, an increase of 15% from the average daily volume of 479,329 shares. The stock had previously closed at $0.16.

Hemispherx BioPharma (NYSEAMERICAN:HEB) last released its quarterly earnings results on Monday, April 1st. The specialty pharmaceutical company reported ($0.03) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.04. The firm had revenue of $0.24 million for the quarter.

COPYRIGHT VIOLATION NOTICE: “Hemispherx BioPharma (HEB) Stock Price Down 9.4%” was posted by Zolmax and is owned by of Zolmax. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://zolmax.com/investing/hemispherx-biopharma-heb-stock-price-down-9-4/3011898.html.

Hemispherx BioPharma Company Profile (NYSEAMERICAN:HEB)

Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).

Featured Article: Municipal Bonds

Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Brokerages Anticipate Actuant Co.  to Announce $0.40 EPS
Brokerages Anticipate Actuant Co. to Announce $0.40 EPS
Paypex Tops One Day Volume of $24,580.00
Paypex Tops One Day Volume of $24,580.00
Stryker  Releases Q2 2019 Earnings Guidance
Stryker Releases Q2 2019 Earnings Guidance
Observer Price Reaches $0.0030 on Major Exchanges
Observer Price Reaches $0.0030 on Major Exchanges
WisdomTree Total U.S. Dividend Fund  Announces Monthly Dividend of $0.20
WisdomTree Total U.S. Dividend Fund Announces Monthly Dividend of $0.20
doc.com Token  Price Reaches $0.0088
doc.com Token Price Reaches $0.0088


 
© 2006-2019 Zolmax.